Altium Capital Management LP Second Sight Medical Products Inc Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.11 - $4.75 $1.16 Million - $1.78 Million
-373,867 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$4.94 - $9.43 $1.85 Million - $3.53 Million
373,867 New
373,867 $1.85 Million

About SECOND SIGHT MEDICAL PRODUCTS INC

EYES Quotes by TradingView
  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email